BioAtla, Inc. (BCAB)

BioAtla Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-119.24	-123.46	-106.48	-95.4	-35.85	-29.79
Depreciation & Amortization	1.17	1.22	1.2	1.33	1.01	0.86
Loss (Gain) From Sale of Assets	0	0	0.01	0	-	0
Stock-Based Compensation	12.23	13.54	14.56	25.12	3.02	-
Other Operating Activities	-	-	-	-0.69	-1.15	-4.54
Change in Accounts Payable	-6.85	5.28	3.41	7.99	-1.66	3.13
Change in Unearned Revenue	-	-	-	-	-0.43	19.76
Change in Other Net Operating Assets	0.49	-0.6	-3.12	-0.57	-1.27	0.94
Operating Cash Flow	-112.19	-104.02	-90.42	-62.21	-36.33	-9.65
Capital Expenditures	-0.05	-0.1	-0.27	-0.92	-0.59	-1.51
Sale of Property, Plant & Equipment	-	-	0	-	-	-
Investing Cash Flow	-0.05	-0.1	-0.27	-0.92	-0.59	-1.51
Long-Term Debt Issued	-	-	-	-	3.43	4
Net Debt Issued (Repaid)	-	-	-	-	3.43	4
Issuance of Common Stock	0.34	0.34	61.97	71.42	200.23	-
Repurchase of Common Stock	-0.16	-0.26	-0.76	-	-	-
Other Financing Activities	-	-	-	-1.91	-4.34	-0.01
Financing Cash Flow	0.18	0.08	61.21	69.51	271.83	4
Net Cash Flow	-112.06	-104.04	-29.47	6.37	234.9	-7.16
Free Cash Flow	-112.24	-104.11	-90.69	-63.14	-36.92	-11.15
Free Cash Flow Margin	-	-	-	-25255.20%	-8606.99%	-214.50%
Free Cash Flow Per Share	-2.34	-2.18	-2.33	-1.83	-4.38	-0.20
Levered Free Cash Flow	-70.63	-61.29	-51.52	-48.83	-9.12	-16.93
Unlevered Free Cash Flow	-70.63	-61.29	-51.52	-48.83	-8.25	-15.91
Change in Net Working Capital	5.73	-5.1	-0.58	14.07	-13.98	-8.81

Source: S&P Capital IQ. Standard template.